“…The severe clinical manifestations and the absence of an effective therapy make this group of sulphatide-lipidoses a major indication for prenatal diagnosis. Prenatal diagnosis of MLD is possible by ASA determination on cultured amniotic cells obtained by amniocentesis (Booth et al, 1972;Leroy et al, 1973;Van Der Hagen, 1973;Rattazzi and Davidson, 1977) or, in some late-presenting pregnancies, on fetal blood collected at fetoscopy (Rodeck et al, 1983). The main disadvantage of these methods is the late pregnancy termination in the case of an affected fetus.…”